Author: dewe67

COVID-19 vaccine. Should we prioritize efficiency or equity?

In this episode of CareTalk, CareCentrix CEO John Driscoll and I tussle about whether to emphasize equity or efficiency in the rollout of the COVID-19 vaccine. John’s in the equity camp while I lean more toward efficiency and broader societal impact and challenge whether there is actually a tradeoff.

Interview with Joel Morse, Curavit CEO

joel opening pittston
Joel Morse, Curavit CEO

Joel Morse has devoted his career to building innovative companies that serve the pharmaceutical industry. His latest venture, Curavit Clinical Research runs decentralized or virtual trials, which have grown dramatically in the pandemic. 

I’m a big fan –and will be a panelist on a Curavit-sponsored webinar:  Are You Ready to Go Virtual? Unlocking the Full Potential of Decentralized Clinical Trials.  The webinar is on March 11 at 1 pm EST. Register here.

In this episode of the HealthBiz podcast, Joel talks about decentralized trials and why they’re growing. He also opens up about his experience building C3i, and how it led him to adventures around the world, including Joel’s involvement with the royal family in Bulgaria.

Check out the rough (AI generated) transcript.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.


By healthcare business consultant David E. Williams, president of Health Business Group.

Some 2nd shots are canceled. I’m quoted in the Boston Globe

Some urgent care clinics have run out of vaccines and cancelled follow-up shots for certain patients. It’s maddening for affected patients, but not a public health problem assuming those shots are given to someone else instead.

I was quoted in the Boston Globe (CareWell clinics telling patients their second COVID-19 shots are canceled, triggering wider vaccination anxieties)

“It’s not surprising,” said David Williams, president of Health Business Group, a Boston management consulting firm. “When you’ve got millions and millions of doses being administered every week, you’d expect to have some sampling of this. You can’t expect everything to go smoothly.”

Delayed appointments are “certainly an inconvenience for the person who was planning to get a second shot, but it’s not a public health problem,” Williams said.

It seems like this glitch has already been addressed. It’s all part of the bumpiness we can expect to continue for a while.


By healthcare business consultant David E. Williams, president of Health Business Group.

Optum buys Atrius Health. I’m quoted in the Boston Globe

United Health’s Optum is purchasing Atrius Health, an independent physician organization in Massachusetts. Atrius has struggled to compete against the huge hospital systems in the state, even though its physician-led approach is more cost effective. Optum’s heft may level the playing field.

I’m quoted in the Boston Globe (Physicians group Atrius Health plans to join Optum, giving a national operation a bigger Mass. footprint)

David E. Williams, president of the consulting firm Health Business Group, said joining Optum would allow Atrius to more aggressively compete with Mass General Brigham (formerly Partners HealthCare) and Beth Israel Lahey.

“With Optum’s backing, Atrius should be able to level the playing field,” he said. “Optum’s ownership will make Atrius less responsive to local needs, but the tradeoff will be worth it if it means Atrius can compete effectively with Partners and BI Lahey.”

Ideally Atrius would stay independent but I don’t thin that’s independent. The company has been losing ground as BI Lahey and MGH Brigham continue their aggressive consolidation of the market. Going with Optum seems like the smartest option for Atrius and the best for the state.

—-

By healthcare business consultant David E. Williams, president of Health Business Group.

Prognos Health CEO Sundeep Bhan on Healthcare Analytics

Sundeep Bhan
Sundeep Bhan, Prognos CEO

Sundeep Bhan’s family liked the idea of him becoming a doctor, but as long as he stayed as a pre-med in college they let him take whatever courses he wanted. He explored art history and communications, and eventually wandered back to healthcare as a company founder. It’s a good thing that he has that entrepreneurial streak, since one of his board members told him he was not employable.

For the past decade, Sundeep has been running Prognos Health, a healthcare analytics platform company. In this episode of the HealthBiz podcast, Sundeep shares why he started the company, the core capabilities required of any player in the space, the evolving meaning of real world data, and how COVID is changing the market.

He’s a big fan of biographies and books on the industry. Sundeep’s favorite biographer is Walter Isaacson; he’s read his books on Steve Jobs, Albert Einstein, and Ben Franklin. For anyone building a platform company, he suggests Platform Revolution by Geoffrey Parker, Marshall van Alstyne and Sangeet Choudary, Hacking Growth by Sean Ellis and Morgan Brown, and Blitzscaling by Reid Hoffman and Chris Yeh.

Check out the rough (AI generated) transcript.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.


By healthcare business consultant David E. Williams, president of Health Business Group.